ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Teva and Neos settle over Cotempla patent dispute
pharmaphorum
December 29, 2018Teva and Neos Therapeutics have reached a confidential settlement and licensing agreement that resolves a patent dispute over the Israeli firm’s generic version of Neos’ ADHD drug Cotempla XR-ODT (methylphenidate).
Pharma Sources Insight July 2025
